TY - JOUR
T1 - Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma
AU - Delgado Jiménez, Yolanda
AU - Camarero-Mulas, Celia
AU - Sanmartín-Jiménez, Onofre
AU - Garcés, Joan R.
AU - Rodríguez-Prieto, Manuel
AU - Alonso-Alonso, Teresa
AU - Miñano Medrano, Roman
AU - López-Estebaranz, Jose L.
AU - de Eusebio Murillo, Esther
AU - Redondo, Pedro
AU - Ciudad-Blanco, Cristina
AU - Toll, Agusti
AU - Artola Igarza, Juan L.
AU - Allende Markixana, Irati
AU - Suarez Fernández, Ricardo
AU - Alfaro Rubio, Alberto
AU - Alonso Pacheco, Marãa L.
AU - Vázquez-Veiga, Hugo
AU - de la Cueva Dobao, Pablo
AU - Ruiz-Salas, Verónica
AU - Vilarrasa, Eva
AU - Barchino, Lucia
AU - Morales-Gordillo, Victoriano
AU - Ocerin-Guerra, Izascun
AU - Navarro Tejedor, Raquel
AU - Hueso, Luis
AU - Mayor Arenal, Matias
AU - Seoane-Pose, Maria J.
AU - Cano-Martinez, Natividad
AU - Garcia-Doval, Ignacio
AU - Descalzo, Miguel A.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - © 2018 The International Society of Dermatology Background: The two main tumors treated with Mohs micrographic surgery (MMS) are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). There are no studies analyzing whether MMS is different when treating these two types of tumors. Objective: We aim to compare the characteristics of the patients, the tumors, and MMS, and first-year follow-up of MMS in BCC and SCC. Methods: REGESMOHS is a prospective cohort study of patients treated with MMS. The participating centers are 19 Spanish hospitals where at least one MMS is performed per week. Data on characteristics of the patients, tumors, and surgery were recorded. The follow-up was done with two visits: the first visit within 1 month after surgery and the second one within the first year. Results: From July 2013 to April 2017, a total of 2,669 patients who underwent MMS were included in the registry. Of them, 2,448 (93%) were diagnosed with BCC, and 181 (7%) were diagnosed with SCC. Patients with SCC were older than those with BCC (median age 73 years vs. 68 years) and presented immunosuppression more frequently. The tumor size was significantly larger in the SCC group. Regarding surgery, deeper invasion was more frequent in SCC, resulting in larger defects. Despite this, SCC did not require more stages to get clear margins or more time in the operating room. Incomplete Mohs was more frequent in the SCC group (6%) than in the BCC group (2%). The incidence of perioperative complications was higher when treating SCC. There were more relapses in the first-year follow-up in the SCC group. Conclusion: There are significant differences when comparing MMS in BCC and SCC. Knowledge of these differences can help to prepare the patient and plan the surgery, optimizing results.
AB - © 2018 The International Society of Dermatology Background: The two main tumors treated with Mohs micrographic surgery (MMS) are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). There are no studies analyzing whether MMS is different when treating these two types of tumors. Objective: We aim to compare the characteristics of the patients, the tumors, and MMS, and first-year follow-up of MMS in BCC and SCC. Methods: REGESMOHS is a prospective cohort study of patients treated with MMS. The participating centers are 19 Spanish hospitals where at least one MMS is performed per week. Data on characteristics of the patients, tumors, and surgery were recorded. The follow-up was done with two visits: the first visit within 1 month after surgery and the second one within the first year. Results: From July 2013 to April 2017, a total of 2,669 patients who underwent MMS were included in the registry. Of them, 2,448 (93%) were diagnosed with BCC, and 181 (7%) were diagnosed with SCC. Patients with SCC were older than those with BCC (median age 73 years vs. 68 years) and presented immunosuppression more frequently. The tumor size was significantly larger in the SCC group. Regarding surgery, deeper invasion was more frequent in SCC, resulting in larger defects. Despite this, SCC did not require more stages to get clear margins or more time in the operating room. Incomplete Mohs was more frequent in the SCC group (6%) than in the BCC group (2%). The incidence of perioperative complications was higher when treating SCC. There were more relapses in the first-year follow-up in the SCC group. Conclusion: There are significant differences when comparing MMS in BCC and SCC. Knowledge of these differences can help to prepare the patient and plan the surgery, optimizing results.
UR - https://www.scopus.com/pages/publications/85053675385
U2 - 10.1111/ijd.14223
DO - 10.1111/ijd.14223
M3 - Article
C2 - 30246444
SN - 0011-9059
VL - 57
SP - 1375
EP - 1381
JO - International Journal of Dermatology
JF - International Journal of Dermatology
ER -
ODS 3: Salud y bienestar